It ain't what you do, it's the way you do it: five golden rules for transforming prostate-specific antigen screening.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 24411991.
- Also identified by DOI 10.1016/j.eururo.2013.12.049.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The benefit-harm ratio of PSA screening can be dramatically improved by avoiding screening, biopsy and treatment in men who are unlikely to benefit, and by referring men that do need treatment to high volume centers.
Medical subject headings
- Early Detection of Cancer
- Prostate
- Prostate-Specific Antigen
- Prostatic Neoplasms